Volta Labs and Hartwig Medical Foundation Collaborate to Advance Oncological Discoveries with the Callisto™ Sample Prep System
May 8, 2025
.png)
Volta Labs and Hartwig Medical Foundation have announced their multi-year collaboration aimed at developing a sample processing platform for the most common cancer diagnostic sequencing applications.
.png)
"We began collaborating with the Volta Labs team two years ago, and we believe the Callisto Sample Prep System represents the future of sample preparation in diagnostic labs. Callisto already delivers an excellent hybrid capture workflow, and we are now working together to enable whole genome sequencing on various DNA sources as well as new capabilities across multiple emerging short-read sequencing platforms. Once development is complete, we plan to integrate the Callisto platform into clinical studies and adopt it for routine use in our clinical accredited testing workflows", said Ewart de Bruijn, Innovation Lead at Hartwig Medical Foundation.
The collaboration between Hartwig and Volta will include advancing the next generation of sample prep “apps” spanning across whole genome sequencing, targeted sequencing, ctDNA, and RNA profiling across multiple sequencing technologies.
About Hartwig:
Hartwig Medical Foundation is a global leader in genomics-driven oncology research and clinical care. They improve cancer patient care by generating, analyzing, and sharing high-quality genomic and clinical data, enhancing diagnostics, enabling personalized treatments, and supporting the development of more effective future therapies.
.webp)
Introducing VoltaHyb:
Automating the Last Mile of Targeted Sequencing Workflows
The Volta Labs team is revolutionizing critical targeted sequencing workflows with the introduction of the VoltaHyb™ suite of Apps and kits for the Callisto™ Sample Prep System. Designed to enrich your targets with confidence every single time, the Callisto platform brings unmatched workflow simplicity to hybridization capture. With Callisto, users no longer need to rely on multiple lab instruments (heated blocks, magnetic racks, vortexers) or perform time-sensitive heated transfer steps - such complex steps are abstracted away from the end user. Furthermore, Callisto's unique architecture enables precise magnetic bead manipulation coupled with uninterrupted and uniform temperature control during the hybrid capture enabling consistent enrichment performance.
Callisto reduces sequencing redo rates to less than 3% while minimizing sample loss throughout the capture process. This breakthrough approach enables reliable targeted sequencing even for challenging applications where conventional tools struggle. These advantages extend across both long and short read-based hybrid capture workflows.
The scalable architecture of the Callisto system enables flexible throughput, with the capacity to process up to 96,000 exomes per year or 48,000 PacBio HiFi samples annually. Whether you're running a small research lab or a high-volume testing facility, Callisto adapts to your needs with flexible batch sizes and consistent performance.
.webp){kind=icon}
Key Benefits
of VoltaHyb for Hybridization Capture:
Reduced Sequencing Costs:
Lower sample preparation and sequencing costs by minimizing reruns (<3% redo rates).Fully Automated Workflow:
Enables complete walk-away automation for hybridization, capture, washes, and PCR setupBroad Panel Compatibility:
Works with panels of all sizes, from small targeted panels to comprehensive exomesSupport for Both Short and Long Read Applications:
Optimized protocols for both Illumina-style short-read sequencing and long-read technologies like PacBio and Oxford Nanopore
Consistent Results:
Dramatically reduced inter-operator variability and robust performance across repeated runsUniform Coverage:
Even coverage across challenging regions, including high-GC content areasMaximum Throughput: Process up to 480 exomes simultaneously with pooled libraries with flexible batching
.webp)
VoltaHyb’s Expanding App Menu
At Volta, we’re continually growing our support for hybrid capture workflows across both short- and long-read sequencing platforms.
On the short-read side, Callisto currently supports IDT xGEN v2 chemistry, as well as Twist’s standard v2 and Fast chemistries. For long-read applications, we support PacBio HiFi enrichment based on Twist’s standard v2 chemistry.
There are more Apps coming to the VoltaHyb menu, and we’re always listening to our users. If there’s a hybrid capture chemistry you’d like to see automated on Callisto, let us know—we’d love to hear from you.
for Twist, v2 standard
The revolution in genomic sample preparation is here. By bringing the push-button experience of a sequencer to targeted sequencing workflows, Volta Labs is transforming how laboratories approach hybridization capture. The choice is no longer between inconsistent manual methods and complex automation platforms that require dedicated engineering resources. With Callisto and VoltaHyb, you can achieve consistent, high-quality results without specialized training or extensive method development.
Ready to experience the difference? Contact our team today to learn how the VoltaHyb powered Hybridization Capture can enhance your targeted sequencing workflows and accelerate your discoveries.
Relevant product pages:
.webp)
Ready to innovate with us?
related posts
.png)
Automating the Last Mile of Targeted Sequencing Workflows on Callisto
.png)
.png)